ace-031
mAbexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00755638)
Timeline
Indications
Mechanism of action
- Activin receptor type-2BINHIBITOR
ACVR2B inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ace-031
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01239758 | Phase 2 | Oct 1, 2010 | Acceleron Pharma, Inc. |
| NCT01099761 | Phase 2 | Apr 1, 2010 | Acceleron Pharma, Inc. |
| NCT00952887 | Phase 1 | Aug 1, 2009 | Acceleron Pharma, Inc., SFBC Anapharm |
| NCT00755638 | Phase 1 | Sep 1, 2008 | Acceleron Pharma, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Acceleron Pharma, Inc. | For profit | 4 | 4 | 2 | 2008 |
| SFBC Anapharm | For profit | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1